FDA Approves the First Oral GLP-1 Drug for Obesity Podcast Por  arte de portada

FDA Approves the First Oral GLP-1 Drug for Obesity

FDA Approves the First Oral GLP-1 Drug for Obesity

Escúchala gratis

Ver detalles del espectáculo

OFERTA POR TIEMPO LIMITADO | Obtén 3 meses por US$0.99 al mes

$14.95/mes despues- se aplican términos.

In this week's roundup, JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "What to Know About the Wegovy Pill for Obesity" and more.

Related Content:

  • What to Know About the Wegovy Pill for Obesity
Todavía no hay opiniones